Insulin Resistance in Patients Undergoing Peritoneal Dialysis: Can We Improve It?

被引：0
|
作者：
King-Morris, Kelli [2 ]
Ikizler, T. Alp [1 ,2 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ Sch Med, Dept Med, Div Nephrol, Nashville, TN USA
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2012年 / 26卷 / 06期
关键词：
CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; INFLAMMATION; STRESS; ROSUVASTATIN; MECHANISMS; EVENTS;
D O I：
10.1007/s10557-012-6423-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：441 / 443
页数：3
相关论文
共 50 条
  • [1] Insulin Resistance in Patients Undergoing Peritoneal Dialysis: Can We Improve It?Editorial to: “The Effect of HM-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis” by Fa Mee Doh et al.
    Kelli King-Morris
    T. Alp Ikizler
    Cardiovascular Drugs and Therapy, 2012, 26 (6) : 441 - 443
  • [2] Can we improve fluid balance and cardiovascular outcomes in peritoneal dialysis patients?
    Woodrow, G
    PERITONEAL DIALYSIS INTERNATIONAL, 2006, 26 (01): : 49 - 52
  • [3] Can biocompatible dialysis fluids improve outcomes in peritoneal dialysis patients?
    Woodrow, G
    PERITONEAL DIALYSIS INTERNATIONAL, 2005, 25 (03): : 230 - 233
  • [4] The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis
    Doh, Fa Mee
    Chang, Tae-Ik
    Koo, Hyang Mo
    Lee, Mi Jung
    Shin, Dong Ho
    Kim, Chan Ho
    Ko, Kwang Il
    Oh, Hyung Jung
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Han, Dae-Suk
    Han, Seung Hyeok
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (06) : 501 - 509
  • [5] The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis
    Fa Mee Doh
    Tae-Ik Chang
    Hyang Mo Koo
    Mi Jung Lee
    Dong Ho Shin
    Chan Ho Kim
    Kwang Il Ko
    Hyung Jung Oh
    Tae-Hyun Yoo
    Shin-Wook Kang
    Dae-Suk Han
    Seung Hyeok Han
    Cardiovascular Drugs and Therapy, 2012, 26 : 501 - 509
  • [6] Hyperleptinaemia, insulin resistance and survival in peritoneal dialysis patients
    Cao, Liou
    Mou, Shan
    Fang, Wei
    Gu, Leyi
    Huang, Jiaying
    Gu, Aiping
    Qian, Jiaqi
    Ni, Zhaohui
    NEPHROLOGY, 2015, 20 (09) : 617 - 624
  • [7] THE EFFECT OF HMG-COA REDUCTASE INHIBITOR ON INSULIN RESISTANCE IN PATIENTS UNDERGOING PERITONEAL DIALYSIS
    Chang, Tae Ik
    Shin, Dong Ho
    Oh, Hyung Jung
    Kang, Shin-Wook
    Han, Dae-Suk
    Yoo, Tae-Hyun
    Han, Seung Hyeok
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 471 - 472
  • [8] Hypovitaminosis D and insulin resistance in peritoneal dialysis patients
    Bindal, Mehmet E.
    Taskapan, Hulya
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (02) : 527 - 534
  • [9] Hypovitaminosis D and insulin resistance in peritoneal dialysis patients
    Mehmet E. Bindal
    Hulya Taskapan
    International Urology and Nephrology, 2011, 43 : 527 - 534
  • [10] More biocompatible peritoneal dialysis solution may improve oxidative stress and insulin resistance in patients receiving continuous ambulatory peritoneal dialysis
    Yang, Shao-Yu
    Chen, Hung-Yuan
    Wu, Ming-Shiou
    Tsai, Tun-Jun
    Wu, Kwan-Dun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 308 - 308
12345